Partner Headlines - ILMN

  1. Short Interest Swings in Biotech Stocks (AMGN, CELG, ONXX)

    Benzinga

  2. UPDATE: Illumina Posts Higher Q4 Profit

    Benzinga

  3. Biogen MS Hopes Trump EPS

    Investors Business Daily

  4. Stocks Turn Mixed, Apple Rises; Stratasys, 3D Systems ...

    Investors Business Daily

  5. Earnings Scheduled For January 28, 2013

    Benzinga

  6. Short Interest Swings in Biotech Stocks (BIIB, CELG, VVUS)

    Benzinga

  7. Illumina, Inc. (ILMN) President & CEO Jay T Flatley ...

    GuruFocus

  8. The Week Ahead: Earnings from Facebook, Ford, ...

    Benzinga

  9. Biogen, Illumina Ready Q4 Reports As Stocks Struggle

    Investors Business Daily

  10. Life Technologies Stock Hits High On Buyout Rumors

    Investors Business Daily

  11. Illumina, Inc. (ILMN) President & CEO Jay T Flatley ...

    GuruFocus

  12. Benzinga's M&A Chatter for Tuesday January 8, 2013

    Benzinga

  13. Illumina plunges as talks falter

    Investors Business Daily

  14. Benzinga's M&A Chatter for Monday January 7, 2013

    Benzinga

  15. Major Averages Record Small Losses to Start Week

    Benzinga

  16. Mid-Day Market Update: SolarCity Wins Big, SunPower ...

    Benzinga

  17. UPDATE: Citigroup Reiterates Illumina at Neutral on ...

    Benzinga

  18. Mid-Morning Market Update: Markets Giving Back Some ...

    Benzinga

  19. Illumina Stock Falls As Roche Says Buyout Talks Fail

    Investors Business Daily

  20. Stock Futures Take A Breather; Nationstar Mortgage Bolts ...

    Investors Business Daily

  21. Benzinga's Top Pre-Market Losers

    Benzinga

  22. A Peek Into The Market Before The Trading Starts

    Benzinga

  23. Illumina to Acquire Verinata Health for $350M

    Benzinga

  24. UPDATE: Wedbush Downgrades Illumina to Neutral on ...

    Benzinga

  25. UPDATE: Piper Jaffray Upgrades Illumina to Overweight on ...

    Benzinga

  26. Benzinga's Top Upgrades

    Benzinga

  27. T. Rowe's Ellenbogen Likes Rackspace and Trimble

    Investors Business Daily

  28. Illumina, Inc. (ILMN) President and CEO Jay T Flatley ...

    GuruFocus

  29. Short Interest Swings in Biotech Stocks (CELG, GILD, REGN)

    Benzinga

  30. Roche eyes Illumina purchase

    Investors Business Daily

  31. Mid-Day Market Update: Steelcase Boosts, Greenbrier Drops

    Benzinga

  32. Illumina Stock Leaps On Roche Acquisition Reports

    Investors Business Daily

  33. Illumina, Inc. (ILMN) President & CEO Jay T Flatley ...

    GuruFocus

  34. Amgen Buying DeCode Genetics To Find Targeted Drugs

    Investors Business Daily

  35. Illumina Starring In Multiple Merger Dramas; Stock Up

    Investors Business Daily

  36. Top Funds Buy Defensive Health Care Stocks

    Investors Business Daily

  37. BioMarin, Prestige Brands and Other Top Performing ...

    Benzinga

  38. RIM, Green Mountain and Other Top Performing Nasdaq ...

    Benzinga

  39. Illumina, Inc. (ILMN) President & CEO Jay T Flatley ...

    GuruFocus

  40. Illumina Stock Falls As Analyst Warns Of Competition

    Investors Business Daily

  41. Illumina Granted Review in Patent Litigation Against ...

    Benzinga

  42. Benzinga's M&A Chatter for Friday November 23, 2012

    Benzinga

  43. Benzinga's M&A Chatter for Wednesday November 21, 2012

    Benzinga

  44. Benzinga's Top Pre-Market Losers

    Benzinga

  45. Parexel International Leads Medical Research Group

    Investors Business Daily

  46. Illumina, Inc. (ILMN) President & CEO Jay T Flatley ...

    GuruFocus

  47. Short Interest Swings in Biotech Stocks (AMGN, BIIB, VRTX)

    Benzinga

  48. Illumina Announce VWR International to Distribute qPCR ...

    Benzinga

  49. Benzinga's M&A Chatter for Wednesday November 7, 2012

    Benzinga

  50. FROM EARLIER: Caris Life Sciences Selects Illumina's ...

    Benzinga

  51. Illumina, Inc. (ILMN) President & CEO Jay T Flatley ...

    GuruFocus

  52. Illumina Inc. Reports Operating Results (10-Q)

    GuruFocus

  53. Short Interest Swings in Biotech Stocks (BIIB, GILD, VVUS)

    Benzinga

  54. From Earlier: Illumina Launches Infinium HumanCore ...

    Benzinga

  55. Illumina Inc. (ILMN) President & CEO Jay T Flatley sells ...

    GuruFocus

  56. Benzinga's M&A Chatter for Tuesday October 2, 2012

    Benzinga

  57. Stocks Open Firm, Slip, End Mixed With Weak Volume

    Investors Business Daily

  58. Stocks Up In Quiet Trade; Illumina, Valspar Rising

    Investors Business Daily

  59. Benzinga's Top Pre-Market Gainers

    Benzinga

  60. Knome Taking Orders for knoSYS™100

    Benzinga

  61. Short Interest in Biotech Firms Resumes (BIIB, GILD, ...

    Benzinga

  62. Benzinga's M&A Chatter for Tuesday September 18, 2012:

    Benzinga

  63. Illumina Gets Order Worth $17M Over Next Five Years

    Benzinga

  64. Illumina Announces TruSeq Stranded mRNA and Total RNA ...

    Benzinga

  65. Short Sellers Shy Away from Biotech Firms

    Benzinga

  66. Illumina Names Paul Bianchi as Senior Vice President of ...

    Benzinga

  67. Illumina Announces Favorable Outcome of its Patent ...

    Benzinga

  68. Baron Funds Comments on Illumina

    GuruFocus

  69. NanoString Technologies Names Dale R. Levitzke Vice ...

    Benzinga

  70. Illumina Inc. Reports Operating Results (10-Q)

    GuruFocus

  71. A Peek Into The Market Before The Trading Starts

    Benzinga

  72. Illumina Countersues IBS and Qiagen for Patent Infringement

    Benzinga

  73. UPDATE: ISI Group Initiates Market Weight, $45 PT on ...

    Benzinga

  74. Top 4 Mid-Cap Stocks In The Biotechnology Industry With ...

    Benzinga

  75. A Peek Into The Market Before The Trading Starts

    Benzinga

  76. Illumina Announces RapidTrack Whole Genome Sequencing ...

    Benzinga

  77. Illumina (ILMN) Loses 2% As Biosciences Stocks Slump

    At Market Intelligence Center

  78. Be Patient As Market Identifies Winners And Losers

    Investors Business Daily

  79. GlaxoSmithKline to Get Hostile with Offer for Human Genome

    Benzinga

  80. Illumina again rejects Roche

    at IBD

  81. Illumina (ILMN) Loses 7.6% after Roche Lets Bid Expire

    At Market Intelligence Center

  82. Illumina Investors Reject Roche, Which Will Walk

    at IBD

  83. Stocks Narrowly Mixed as Earnings and Data Roll in with ...

    At Market Intelligence Center

  84. Call Players Swarm Illumina Ahead of Front-Month Expiration

    By SchaeffersResearch

  85. Stock Post Gains on Positive Data, Earnings with FedEx ...

    At Market Intelligence Center

  86. Illumina

    at IBD

  87. Illumina (ILMN) Loses 2.1% after Roche Insists Current ...

    At Market Intelligence Center

  88. Illumina Falls As Roche Doesn't Raise $6.5 Bil Offer

    at IBD

  89. Call Players Swarm Illumina After Roche Ups its Takeover Bid

    By SchaeffersResearch

  90. Stocks Finish Mixed on Economic Growth Worries with Best ...

    At Market Intelligence Center

  91. Roche

    at IBD

  92. Stocks Drop in Early Trading on Economic Growth Worries ...

    At Market Intelligence Center

  93. Illumina (ILMN) Gains 4.4% After Roche Raises Bid, Says ...

    At Market Intelligence Center

  94. Roche Ups Bid For Illumina 15% To $51 A Share

    at IBD

  95. Jobs Data Trip Stock Futures; Red Hat, Illumina Gain

    at IBD

  96. Roche touts bid for Illumina

    at IBD

  97. Illumina's Technical Prowess Doesn't Dissuade Bears

    By SchaeffersResearch

  98. Roche

    at IBD

  99. Notable Call Options Activity in Illumina

    at Benzinga

  100. UPDATE: Illumina Announces Outcome of First Phase of Its ...

    at Benzinga
Marketplace
Trading Center